DOI: 10.1055/s-00050348

Indian Journal of Medical and Paediatric Oncology

References

Hijioka S, Hosoda W, Matsuo K. et al.
Rb Loss and KRAS mutation are predictors of the response to platinum-based chemotherapy in pancreatic neuroendocrine neoplasm with grade 3: a Japanese multicenter pancreatic NEN-G3 study.

Clin Cancer Res 2017;
23 (16) 4625-4632

Download Bibliographical Data

Access:
Access: